IP Library Granted Patent US 7,939,099
Granted Patent B2
US 7,939,099 · App. 10/537,401 · Granted May 10, 2011

Sustained improver of muscular fatigue

Assignees: Meiji Dairies Corporation; Kyowa Hakko Bio Co. Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,939,099
App. No.
10/537,401
Granted
May 10, 2011
Kind
B2
Abstract

A long-acting improver of muscular fatigue characterized by comprising 4 kinds of amino acids made up of leucine, isoleucine, valine and glutamine, and a whey protein component (whey protein and/or decomposition product of whey protein). At least one of a whey protein isolate (WPI), a whey protein concentrate (WPC), β-lactoglobulin, and α-lactalbumin is used as the whey protein. Novel food or drink, and pharmaceuticals which exhibit sustained recovery effects on muscular fatigue are provided.

Claims (6)

1. A composition for a sustained treatment of muscular fatigue, which consists of leucine, isoleucine, valine, glutamine and a whey protein component, wherein the whey protein component is at least one selected from the group consisting of a whey protein isolate, a whey protein concentrate, β-lactoglobulin, α-lactalbumin, and a whey protein hydrolysate.

2. The composition according to claim 1 , wherein the amount of leucine is 10 to 30 parts by weight, the amount of isoleucine is 5 to 15 parts by weight, the amount of valine is 5 to 15 parts by weight, the amount of glutamine is 5 to 15 parts by weight, and the amount of the whey protein component is 75 to 25 parts by weight, each based on the total weight of the composition.

3. The composition according to claim 1 , wherein the amount of leucine is 20 parts by weight, the amount of isoleucine is 10 parts by weight, the amount of valine 10 parts by weight, the amount of glutamine is 10 parts by weight, and the amount of the whey protein component is 50 parts by weight, each based on the total weight of the composition.

4. A method of sustainably treating muscular fatigue, which comprises administering a composition consisting of leucine, isoleucine, valine, glutamine and a whey protein component to a subject in need of sustained treatment of muscular fatigue, wherein the whey protein component is at least one selected from the group consisting of a whey protein isolate, a whey protein concentrate, β-lactoglobulin, α-lactalbumin, and a whey protein hydrolysate.

5. The method according to claim 4 , wherein the composition consists of leucine in an amount of 10 to 30 parts by weight, isoleucine in an amount of 5 to 15 parts by weight, valine in an amount of 5 to 15 parts by weight, glutamine in an amount of 5 to 15 parts by weight, and the whey protein component in an amount of 75 to 25 parts by weight based on the total weight of the composition.

6. The method according to claim 4 , wherein the composition consists of leucine in an amount of 20 parts by weight, isoleucine in an amount of 10 parts by weight, valine in an amount of 10 parts by weight, glutamine in an amount of 10 parts by weight, and the whey protein component in an amount of 50 parts by weight based on the total weight of the composition.

Assignments (4)
NUNC PRO TUNC ASSIGNMENT Recorded Dec 30, 2022
From: MEIJI CO., LTD.
To: KYOWA HAKKO BIO CO., LTD.
Reel/Frame 062241/0894 →
CHANGE OF NAME & ADDRESS Recorded Dec 30, 2022
From: MEIJI DAIRIES CORPORATION
To: MEIJI CO., LTD.
Reel/Frame 062251/0839 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2009
From: KYOWA HAKKO KOGYO CO., LTD.
To: KYOWA HAKKO BIO CO., LTD.
Reel/Frame 022399/0600 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2005
From: TSUCHITA, HIROSHI; SAITO, MASATO; KAMIYA, TOSHIKAZU; KOMATSU, MIHO
To: MEIJI DAIRIES CORPORATION; KYOWA HAKKO KOGYO CO., LTD.
Reel/Frame 017715/0933 →
Priority Claims (1)
JP 2002-350200 · Dec 2, 2002 · national
Continuity (1)
Related Publication 20060127492A1 · Jun 15, 2006